These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3177254)

  • 21. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
    Buzzoni R; Bonadonna G; Valagussa P; Zambetti M
    J Clin Oncol; 1991 Dec; 9(12):2134-40. PubMed ID: 1960555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adriamycin and mitomycin C as initial chemotherapy for advanced breast cancer.
    Amiel SA; Stewart JF; Earl HM; Knight RK; Rubens RD
    Eur J Cancer Clin Oncol; 1984 May; 20(5):631-4. PubMed ID: 6428893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancer.
    Legha SS; Benjamin RS; Mackay B; Yap HY; Wallace S; Ewer M; Blumenschein GR; Freireich EJ
    Cancer; 1982 May; 49(9):1762-6. PubMed ID: 7074581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined chemoendocrine therapy using adriamycin, cyclophosphamide and high dose toremifene in patients with recurrent breast cancer].
    Wada N; Kobayashi H; Oka S; Ando J; Tamura H
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1935-42. PubMed ID: 12465393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
    Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
    Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
    Woodcock TM; Schneider RJ; Young CW
    Cancer Treat Rep; 1980 Jan; 64(1):53-5. PubMed ID: 6892893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of metastatic breast cancer with paclitaxel and doxorubicin.
    Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BW; Ejlertsen B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):13-7. PubMed ID: 8643964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer.
    Sayer HG; Schilling K; Vogt T; Blumenstengel K; Issa MC; Mügge LO; Kasper C; Kath R; Höffken K
    J Cancer Res Clin Oncol; 2003 Jun; 129(6):361-6. PubMed ID: 12884031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of bolus tetrahydropyranyl adriamycin and 120 hours continuous 5-fluorouracil infusion in patients with metastatic breast cancer.
    Chevallier B; Fumoleau P; Kerbrat P; Monnier A; Roche H; Goudie MJ; Herait P
    Am J Clin Oncol; 1990; 13 Suppl 1():S40-3. PubMed ID: 2291456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicity trials of amsacrine (AMSA) and etoposide +/- azacitidine (AZ) in childhood acute non-lymphocytic leukemia (ANLL): a pilot study.
    Steuber CP; Holbrook T; Camitta B; Land VJ; Sexauer C; Krischer J
    Invest New Drugs; 1991 May; 9(2):181-4. PubMed ID: 1714886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of advanced colorectal carcinoma with AMSA.
    Ferraro JA; Horton J; Weissman C; Ruckdeschel JC; O'Donnell M; Ludlum D
    Cancer Treat Rep; 1981; 65(3-4):345-7. PubMed ID: 6894563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I/II study of continuous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: a Japan Clinical Oncology Group (JCOG) study 9113. JCOG Breast Cancer Study Group.
    Ikeda T; Adachi I; Takashima S; Ogita M; Aoyama H; Sano M; Ando J; Tabei T; Tominaga T; Enomoto K; Kanda K; Fukutomi T; Shimoyama M
    Jpn J Clin Oncol; 1999 Jan; 29(1):23-7. PubMed ID: 10073147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic efficacy of pirarubicin cyclophosphamide and doxifluridine in advanced and metastatic breast cancer].
    Inoue K; Tabei T; Suemasu K; Higashi Y; Kurosumi M
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):637-42. PubMed ID: 10234294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclophosphamide, adriamycin, 5-fluorouracil and high-dose toremifene for patients with advanced/recurrent breast cancer. The Japan Toremifene Cooperative Study Group.
    Tominaga T; Nomura Y; Uchino J; Hirata K; Kimura M; Yoshida M; Aoyama H; Kinoshita H; Koyama H; Monden Y; Takashima S; Ogawa M
    Jpn J Clin Oncol; 1998 Apr; 28(4):250-4. PubMed ID: 9657010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer.
    Gabra H; Cameron DA; Lee LE; Mackay J; Leonard RC
    Br J Cancer; 1996 Dec; 74(12):2008-12. PubMed ID: 8980405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An effective low-dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patients.
    Creech RH; Catalano RB; Shah MK
    Cancer; 1980 Aug; 46(3):433-7. PubMed ID: 7397618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer.
    Schwartsmann G; Mans DR; Menke CH; Xavier N; Caleffi M; Ferreira Filho AF; Schunemann H; Kalakun L; Koya R; Pohlman P; Venegas LF
    Oncology (Williston Park); 1997 Apr; 11(4 Suppl 3):24-9. PubMed ID: 9144687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the interval between the administration of doxorubicin and paclitaxel on the pharmacokinetics of these drugs in patients with locally advanced breast cancer.
    Moreira A; Lobato R; Morais J; Silva S; Ribeiro J; Figueira A; Vale D; Sousa C; Araújo F; Fernandes A; Oliveira J; Passos-Coelho JL
    Cancer Chemother Pharmacol; 2001 Oct; 48(4):333-7. PubMed ID: 11710635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.